Extended-Release Naltrexone Seems as Effective as Standard Treatment for Opioid Dependence (FREE)
By Amy Orciari Herman
Edited by Susan Sadoughi, MD
Injectable extended-release naltrexone (Vivitrol) appears to be as safe and effective as daily oral buprenorphine-naloxone for treating opioid dependence, according to a Norway-based, noninferiority trial …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news